Listen "The First $100 Billion Drug"
Episode Synopsis
BofA analyst Geoff Meacham talks about downgrading Pfizer, upgrading Merck, and what he thinks will become the best selling medicine of all time.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Learn more about your ad choices. Visit megaphone.fm/adchoices
More episodes of the podcast Barron's Streetwise
Pensions, Naked Puts, Low-Sin Investing
26/12/2025
Andrew Bary’s Top Stocks for 2026
19/12/2025
Amazon’s Rufus Sales Tactics
28/11/2025
Earnings Season Was Surprisingly Surprising
07/11/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.